Anti-tumour effects of perioperative ketamine in lung cancer: a non-randomised, exploratory biomarker study
- PMID: 40935722
- DOI: 10.1016/j.bja.2025.08.004
Anti-tumour effects of perioperative ketamine in lung cancer: a non-randomised, exploratory biomarker study
Keywords: biomarkers; circulating endothelial cells (CECs); circulating tumour cells; ketamine; liquid biopsy; non-small cell lung cancer (NSCLC).
Conflict of interest statement
Declaration of interest The HDSCA technology described here is licensed to Epic Sciences. PK has ownership in Epic Sciences. All other authors declare that they have no conflicts of interest.
Publication types
LinkOut - more resources
Full Text Sources